# Stroke Prevention In Ischemic Stroke With Covert Atrial Fibrillation

> **NCT06486792** · PHASE4 · NOT_YET_RECRUITING · sponsor: **Assistance Publique - Hôpitaux de Paris** · enrollment: 1148 (estimated)

## Conditions studied

- Stroke
- Ischemic Stroke
- Cerebral Infarction
- Atrial Fibrillation

## Interventions

- **DRUG:** Apixaban
- **DRUG:** Aspirin

## Key facts

- **NCT ID:** NCT06486792
- **Lead sponsor:** Assistance Publique - Hôpitaux de Paris
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2024-09-01
- **Primary completion:** 2025-09-01
- **Final completion:** 2028-03-01
- **Target enrollment:** 1148 (ESTIMATED)
- **Last updated:** 2024-07-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06486792

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06486792, "Stroke Prevention In Ischemic Stroke With Covert Atrial Fibrillation". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06486792. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*